NEW HAVEN, Conn., Nov. 4 /PRNewswire/ -- Achillion Pharmaceuticals, Inc.,
a leader in the discovery and development of small molecule drugs to combat
the most challenging infectious diseases, today announced that Michael D.
Kishbauch, Chief Executive Officer of Achillion, will be presenting a
corporate overview and update on the Company's clinical programs in HIV and
HCV at the following upcoming investment conferences:
* CIBC World Markets Healthcare Conference - Monday, November 7, 2005 at
11:00 am at the Waldorf-Astoria in New York City
* Rodman & Renshaw Techvest 7th Annual Healthcare Conference - Wednesday,
November 9, 2005 at 2:50 pm at the New York Palace Hotel in New York
City
About Achillion
Achillion is an innovative pharmaceutical company dedicated to bringing
important new treatments to patients with infectious disease. The company's
proven discovery and development teams have advanced multiple product
candidates with novel mechanisms of action. Achillion is focused on solutions
for the most challenging problems in infectious disease -- HIV, hepatitis and
resistant bacterial infections. For more information on Achillion
Pharmaceuticals, please visit the company's web site at
http://www.achillion.com or call Achillion at 1-203-624-7000.
This news release contains certain forward-looking statements that involve
risks and uncertainties. Such statements are only predictions and actual
results may differ materially from those anticipated in these forward-looking
statements. Factors that may cause such differences include the risk that
products that appeared promising in early research and clinical trials do not
demonstrate safety or efficacy in larger-scale clinical trials and the risk
that the company will not obtain approval to market its products.
SOURCE Achillion Pharmaceuticals, Inc.
 back to top
Related links:
http://www.achillion.com
CONTACT:
Jonas M. Niaura of Achillion Pharmaceuticals,
Inc., +1-203-752-5486; or Kari Watson of MacDougall Biomedical
Communications, Inc., +1-508-647-0209, kwatson@macbiocom.com
|
